top of page

BioLargo Engineering Awarded U.S. Air Force Subcontracts

WESTMINSTER, CA, July 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – BioLargo, Inc. (OTCQB: BLGO), developer of sustainable products and a full-service environmental engineering company, today announced that its engineering subsidiary has been awarded two subcontracts to provide air quality environmental engineering services to five United States Air Force (USAF) bases in Texas and Arizona.

BioLargo Engineering, Science & Technologies (BLEST; has entered into a series of “teaming agreements” with Bhate Environmental Associates, Inc. (, as prime-contractor, to prepare bids for submission to the U.S. General Services Administration (GSA) for environmental services on Air Force bases throughout the country. Bhate assembled a multi-disciplined team of five companies, including BLEST, to provide services to the USAF in what is commonly referred to as “fence-to-fence environmental services” call orders.  These fence-to-fence (F2F) projects include a menu of environmental engineering services, which focus on hazardous waste, hazardous materials, air quality, water quality, natural and cultural resources.

The total value of these two contracts awarded to Bhate exceeds $12 million over a five-year term, of which the subcontractors will receive a portion (first year guaranteed, and GSA can extend for four additional years). In addition to these awarded contracts, BLEST is working closely with Bhate to pursue similar environmental projects for the USAF which are in various stages of bids and consideration.

Randall Moore, President of BioLargo Engineering, commented, “Our team has significant experience and expertise in this particular area of practice, and we are proud to serve our country and the US Air Force. We look forward to working hand-in-hand with Bhate on these first contracts as well as future successful bids.”

Dennis P. Calvert, President of BioLargo, Inc., commented, “These government contracts validate the wisdom of adding Randy and his team of engineering professionals to the BioLargo family of companies. Our investments in technologies and talent continue to pay off.”

About BioLargo, Inc.

BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" ( Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship ( Our industrial odor control division, Odor-No-More ( features CupriDyne Clean Industrial Odor Eliminator (, which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water ( develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical ( features effective and gentle solutions for chronic wounds to promote infection control and regenerative tissue therapy.

Safe Harbor Act

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Contact Information: Dennis Calvert  President and CEO  BioLargo, Inc.  888-400-2863

Recent Posts

See All

1 Kommentar

Arthur Kaufman
Arthur Kaufman
30. Juli 2022

Thanks great bllog

Gefällt mir
bottom of page